Retroviruses can utilize a variety of cellsurface proteins for binding and entry into cells, and the cloning of several of these viral receptors has allowed refinement of models to explain retrovirus tropism. A single receptor appears to be necessary and sufficient for entry of many retroviruses, but exceptions to this simple model are accumulating. For example, HIV requires two proteins for cell entry, neither of which alone is sufficient; lOAl murine leukemia virus can enter cells by using either of two distinct receptors; two retroviruses can use different receptors in some cells but use the same receptor for entry into other cells; and posttranslational protein modifications and secreted factors can dramatically influence virus entry. These findings greatly complicate the rules governing retrovirus tropism. The mechanism underlying retrovirus evolution to use many receptors for cell entry is not clear, although some evidence supports a mutational model for the evolution of new receptor specificities. Further study of factors that govern retrovirus entry into cells are important for achieving high-efficiency gene transduction to specific cells and for the design of retroviral vectors to target additional receptors for cell entry.
Many features make retrovirus vectors a good choice for gene transfer into animal cells. Most importantly, these vectors integrate efficiently into the target cell genome to promote stable gene transfer, and integration is precise with respect to the virus genome, resulting in unrearranged transfer of the desired genes. The only other integrating vector is derived from adeno-associated virus, but integration is inefficient (1) and appears not to be precise with respect to the viral genome (2) . In addition, retroviral vectors can transduce both dividing and non-dividing cells, although this is true of vectors derived from HIV (3) and not the commonly used vectors derived from murine leukemia viruses, which require cell division (4) . Furthermore, retrovirus vectors can be designed to eliminate all viral protein coding regions without affecting gene transfer rates, and can be made in the absence of replication-competent virus by using retrovirus packaging cell lines, which supply all of the viral proteins required for vector transmission. Gene transfer and expression mediated by such replicationincompetent vectors is called transduction to differentiate this process from virus infection followed by further virus replication.
A key consideration in retroviral vector design is the source of the viral envelope (Env) protein present on vector virions, because this protein binds to specific cell-surface proteins and is the primary determinant of the range of cells that can be transduced by the vector. The name of the virus or the virus group from which the Env protein was derived will be referred to as the pseudotype of the vector. Naturally occurring retroviruses can use a variety of different proteins for cell entry, although in general individual retroviruses appear to recognize-a single receptor. Utilization of additional cell-surface proteins for vector entry has been achieved by incorporation of polypeptides into the Env protein to alter its receptor binding properties or by replacement of the retroviral Env protein with surface proteins from other viruses. These alterations can allow targeting of particular cells that express specific proteins or an expansion of the range of cells that can be transduced by targeting broadly expressed proteins. In this paper I will review the factors that govern retrovirus binding and entry into cells and implications for the design of retroviral vectors.
Virus Interference
Early evidence that retroviruses use multiple receptors for cell entry (12, 13) . Since then, six additional retrovirus receptors have been identified and their cDNAs cloned ( Table  2 ). All except CD4 appear to be sufficient for entry of the corresponding retroviruses by the criteria that expression of these receptors in nonpermissive cells renders the cells susceptible to infection. In contrast, CD4 transfer into nonpermissive mouse cells does not allow infection by HIV. HIV binds to all cells that express CD4, but another factor is required for HIV entry. Recently, a coreceptor for T-cell tropic HIV-1 strains has been found and was named fusin to indicate its presumed role in virus entry following HIV-1 binding to CD4 (14) . Expression of the human CD4 and fusin proteins in mouse cells renders the cells susceptible to HIV-1 infection, whereas either protein alone is insufficient. Even Two of the cloned retrovirus receptors, Raml and Glvrl, are closely related at the protein sequence level (21, 22, 24) , and both are sodium-dependent phosphate transporters (23) . These proteins are members of a large family of known and presumptive phosphate transporters from many organisms (Fig. 1) . However, Raml and Glvrl are clearly distinct since the genes encoding these proteins are located on different chromosomes in humans and mice (8, 9, 30, 31) and they show very different patterns of expression in animal tissues (23 (Fig. 4) . For IOAI virus, which targets Raml or Glvrl for entry (32, 38) .
However, because Raml and Glvrl are related proteins, this change does not represent a dramatic switch in receptor specificity, and it will be interesting to see if minor amino acid changes in Env proteins can result in more dramatic changes in receptor utilization.
Endogenous Synthesis of Env Protein Can Block Retrovirus Entry
Retrovirus receptors can be rendered nonfunctional due to blockade by Env protein synthesized by a replicationcompetent retrovirus. This is the basis for the virus interference discussed above. Interference with receptor function can also result from synthesis of Env proteins from endogenous retroviruses or fragments of retroviruses that are inherited in animals. A well-documented example of this phenomenon involves the Fv-4 locus in mice (39) , the phenotype of which is due to a truncated endogenous ecotropic retrovirus that is missing the gag and part of the pol genes, but which contains an intact env gene. Synthesis of this endogenous env gene product in mouse tissues blocks infection and leukemia caused by ecotropic retroviruses by blocking the ecotropic retrovirus receptor. Other examples of this phenomenon have been found for avian leukosis viruses in chickens (40) and for MCF viruses in mice (41) .
Hamster Cells Secrete a Factor That Blocks Retrovirus Infection and a Similar Factor Is Found in Hamster Serum CHO cells are resistant to infection by many retroviruses. In most cases, this resistance can be abrogated by prior treatment of the cells with the glycosylation inhibitor tunicamycin. The resistance to GALV and amphotropic retrovirus infection is due to a secreted protein factor that blocks infection (42 Hamster serum contains a similar factor that can block retrovirus infection of tunicamycin-treated CHO cells (Table  6 ). Addition of 5% serum from Chinese hamsters completely blocked transduction by an amphotropic vector, and 12.5% serum from Syrian hamsters also significantly inhibited transduction. In contrast, addition of 25% fetal bovine serum had no effect on transduction of tunicamycin-treated CHO cells by the amphotropic vector. Like the CHO cell-conditioned medium, the hamster sera had no effect on amphotropic vector infection of HeLa human cells ( different pseudotypes. Approximate host ranges of packaging cells derived using mammalian retroviruses are shown in Table  7 . A listing of specific packaging cell lines can be found in ref. 46 . The best vector pseudotype for a given application will be further influenced by the specific target tissue and the expression of suitable levels of receptors with proper posttranslational modifications to allow efficient virus entry. For example, Glvrl is overexpressed compared with Raml in hematopoietic cells (23) , and vectors with a GALV pseudotype have been found to transduce hematopoietic cells more efficiently than the same vectors with an amphotropic pseudotype (47, 48) .
Conclusions
Retroviruses utilize a diverse set of proteins for cell entry. Single proteins are apparently required for binding and entry of most retroviruses, although two proteins are required for HIV. Although virus entry is dependent on the level of receptor expression in particular cells, there are many other factors that govern utilization of a receptor or its homologs in different species. Subtle alterations in the amino acid sequence of receptor homologs in different species can dramatically affect virus entry, either as a direct result of changes in the primary amino acid sequence or as an indirect result of altered protein modifications such as glycosylation. Indeed, restricted virus host range is not generally due to a lack of expression of homologous receptor proteins, but is more often related to minor alterations in these proteins. In addition, soluble proteins secreted by some cells and present in some animals, and retroviral Env proteins synthesized from replicationcompetent viruses or from endogenous virus sequences, can block receptor utilization. These are all important considerations in the design of retroviral vectors for gene transfer in cultured cells and in animals.
Recently it has become clear that certain retroviruses can use more than one receptor for entry into some cell types, and some receptors can promote entry of retroviruses that normally utilize different receptors in other cells. These results seriously complicate attempts to classify retroviruses into groups based on receptor utilization, as determined by interference analysis, because these groupings depend on the particular receptors expressed on the cell type used for the analysis. In fact, this problem was appreciated long before the molecular basis for this phenomenon was determined (49) .
Further development of retroviral vectors for gene transfer applications has involved the incorporation of Env proteins (51, 52 ). An understanding of the principles governing cell entry by naturally occurring retroviruses will help in the design and application of these strategies. A fascinating aspect of retroviruses is their utilization of diverse proteins for cell entry. The analysis presented here favors a mutational basis for retrovirus evolution to utilize new receptors, rather than acquisition and expression of cellular proteins that naturally bind to cell-surface receptors, but more information is needed to resolve this issue. Perhaps analysis of additional naturally occurring retroviruses and their receptors will reveal a clear example of acquisition of a cellular gene that enables utilization of a new cell-surface receptor for entry. Answers to these questions have important implications for the design of retroviral vectors with novel receptor specificities, and for the evolution of retroviruses, which are important agents of disease in humans and in animals.
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